asa guidelines on glp-1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine Researchers find GLP-1 medications safe

Gastric balloon manufacturer Allurion Technologies is taking a similar approach

According to the FDA prescribing information for both medications, frequent urination is not listed among the common adverse reactions observed in clinical trials

My best guess is some sort of activation of the RAAS system is happening to lower blood pressure along with the increase in urination seen with GLP-1 medications

Higher than normal readings may indicate the presence of prostate cancer

Here are the pros and cons of using GLP-1 antagonists

This novel treatment, nearing Phase 1 clinical trials, could help prevent weight regain post-GLP-1 analogue use by mimicking the incretin hormone to suppress appetite and regulate blood sugar, thus aiding in the management of obesity and diabetes